Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

BACKGROUND: In daily clinical setting, some patients affected by relapsing-remitting Multiple Sclerosis (RRMS) are switched from the low-dose to the high-dose Interferon beta (IFNB) in order to achieve a better control of the disease. PURPOSE: In this observational, post-marketing study we reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperini, Luca, Borriello, Giovanna, De Giglio, Laura, Leonardi, Laura, Barletta, Valeria, Pozzilli, Carlo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058026/
https://www.ncbi.nlm.nih.gov/pubmed/21352517
http://dx.doi.org/10.1186/1471-2377-11-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058026/
https://www.ncbi.nlm.nih.gov/pubmed/21352517
http://dx.doi.org/10.1186/1471-2377-11-26

Ejemplares similares